RachelWLinnemannMD

Attending Physician, Children’s Healthcare of Atlanta Associate Professor, Emory University School of Medicine

Dr. Linnemann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1400 Tullie Rd NE
Fl 5
Atlanta, GA 30329
Phone+1 404-785-5437

Fax+1 404-785-9087

Pragmatic Implementation Trial of a CF Primary Palliative Care Intervention Start of enrollment: 2021 Jun 25
Active, not recruiting
Not Applicable
Roles: Contact, Principal Investigator
Trikafta in Cystic Fibrosis Patients Start of enrollment: 2019 Sep 04
Recruiting
Phase 2
Roles: Contact

PubMed

90 citations
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Op...
Matthias Griese, Stefano Costa, Rachel W. Linnemann, Marcus A. Mall, Edward F. McKone
American Journal of Respiratory and Critical Care Medicine. 2021-02-01
22 citations
The CF-CARES primary palliative care model: A CF-specific structured assessment of symptoms, distress, and coping
Deborah Friedman, Rachel W. Linnemann, Lily L. Altstein, Suhayla Islam, Kieu-Tram Bach
Journal of Cystic Fibrosis. 2017-06-01
46 citations
Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study.
Kohei Hasegawa, Rachel W. Linnemann, Jonathan M. Mansbach, Nadim J. Ajami, Janice A. Espinola
The Pediatric Infectious Disease Journal. 2017-11-01

Transition Planning for Chronic Illnesses in the Time of COVID-19December 3rd, 2020